| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| Sale of goods | 4 | ||
| Rendering of services | |||
| Revenue | |||
| Change in obsolescence provision | 12 | ||
| Cost of goods sold | 5.1 | ||
| Gross profit | |||
| Research and development expenses | 5.4 | - |
- |
| Sales and marketing expenses | 5.5 | - |
- |
| Operational / supply chain expenses | 5.6 | - |
- |
| Administrative expenses | 5.7 | - |
- |
| Depreciation, amortisation and net impairment losses | 8, 9, 11 | - |
- |
| Operating profit / loss (-) | - |
- |
|
| Finance income | 5.9 | ||
| Finance costs | 5.9 | - |
- |
| Net financial items | |||
| Profit / loss (-) before tax | - |
- |
|
| Income tax expense | 6 | - |
- |
| Profit / loss (-) for the year | - |
- |
|
| Attributable to: | |||
| Equity holders of the parent | - |
- |
|
| Non-controlling interests | |||
| Earnings per share: | |||
| Basic, attributable to ordinary equity holders of the parent (NOK) | 7 | - |
- |
| Diluted, attributable to ordinary equity holders of the parent (NOK) | 7 | - |
- |
| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| Profit / loss (-) for the year | - |
- |
|
| Other comprehensive income | |||
| Exchange differences on translation of foreign operations | - |
||
| Income tax effect | |||
| Net other comprehensive income to be reclassified to profit or loss in subsequent periods | - |
||
| Total comprehensive income for the year, net of tax | - |
- |
|
| Attributable to: | |||
| Equity holders of the parent | - |
- |
|
| Non-controlling interests |
| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| ASSETS | |||
| Property, plant and equipment | 8 | ||
| Intangible assets | 9 | ||
| Right-of-use assets | 11 | ||
| Total non-current assets | |||
| Inventories | 12 | ||
| Trade and other receivables | 13.1, 14 | ||
| Prepayments | |||
| Cash and cash equivalents | 15 | ||
| Total current assets | |||
| Total assets | |||
| EQUITY AND LIABILITIES | |||
| Share capital | 16 | ||
| Share premium | 16 | ||
| Translation reserve | |||
| Retained earnings | |||
| Total equity | |||
| Interest-bearing loans and borrowings | 13.2 | ||
| Lease liabilities | 11, 13.2 | ||
| Total non-current liabilities | |||
| Trade and other payables | 13.2 | ||
| Interest-bearing loans and borrowings | 13.2 | ||
| Current lease liabilities | 11, 13.2 | ||
| Provisions | 17 | ||
| Total current liabilities | |||
| Total liabilities | |||
| Total equity and liabilities |
| Grethe Viksaas (sign) Chairperson | Svenn-Tore Larsen (sign) Board member | Jean-Christophe Eloy (sign) Board member | Marianne Bøe (sign) Board member |
|---|---|---|---|
| Cathrine Wiig Ore (sign) | Chris Liu (sign) | Louis So (sign) | Dr Øyvind Isaksen (sign) |
| Board member | Board member | Board member | Chief Executive Officer |
| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| Operating activities | |||
| Profit / loss (-) before tax | - |
- |
|
| Adjustments for: | |||
| Depreciation and impairment of property, plant and equipment and right-of-use assets | 8 | ||
| Amortisation and impairment of intangible assets | 9 | ||
| Net finance income | 5.9 | - |
- |
| Equity-settled share-based payments | 5.3 | ||
| Gain on disposal of property, plant and equipment | - |
||
| Other non-cash items | - |
- |
|
| Changes in unrealised net foreign exchange rate differences/fluctuations | - |
- |
|
| Changes in working capital: | |||
| Increase (-) in trade and other receivables and prepayments | - |
||
| Decrease (+) in inventories | 12 | ||
| Increase (+) in trade and other payables | - |
||
| Changes in provisions and government grants | 17, 14 | - |
|
| Interest received | 5.9 | ||
| Interest paid | 5.9 | - |
- |
| Income tax paid | 6 | - |
- |
| Net cash flows used in operating activities | - |
- |
|
| Investing activities | |||
| Proceeds from sale of property, plant and equipment | |||
| Purchase of property, plant and equipment | 8, 9 | - |
- |
| Net cash flows used in investing activities | - |
- |
|
| Financing activities | |||
| Proceeds from issuance of ordinary shares | 16 | ||
| Proceeds from exercise of share options | 16 | ||
| Transaction costs on issuance of shares | 16 | - |
- |
| Payment of lease liabilities | 11 | - |
- |
| Proceeds from borrowings | 13.2 | ||
| Repayment of borrowings | 13.2 | - |
- |
| Net cash flows from / (used in) financing activities | |||
| Net increase in cash and cash equivalents | |||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Cash and cash equivalents at 1 January | 15 | ||
| Cash and cash equivalents at 31 December | 15 |
| • | Leased building: | The duration of the lease agreement |
| • | Equipment: | 3 to 6 years |
| Software licence | Development costs | |
| Useful lives | Finite (3-5 years) | Finite (3-7 years) |
| Amortisation method used | Amortised on a straight- line basis | Amortised on a straight- line basis over |
| over the lives of the licences | the period of expected consumption of | |
| future economic benefits from the | ||
| related project | ||
| Internally generated or acquired | Acquired | Internally generated |
| • | Disclosures of significant judgements and estimation uncertainty | Note | 3 |
| • | Property, plant and equipment | Note | 8 |
| • | Intangible assets | Note | 9 |
| • | Research and development costs | Note | 10 |
| Geographical distribution | Revenue | |
| (in NOK 000) | 2025 | 2024 |
| America | 8 875 | 4 982 |
| Asia | 10 787 | 4 410 |
| Europe | 822 | 232 |
| Total | 20 484 | 9 624 |
| Geographical distribution | Right-of-use assets | Machinery & equipment | Development costs | |||
| (in NOK 000) | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
| Norway | 10 091 | 10 241 | 2 297 | 3 161 | 3 031 | 10 306 |
| France | 0 | 0 | 0 | 2 | 0 | 0 |
| Finland | 0 | 0 | 35 | 48 | 0 | 0 |
| Taiwan | 0 | 0 | 0 | 2 | 0 | 0 |
| The Philippines | 0 | 0 | 4 243 | 6 338 | 0 | 0 |
| China | 0 | 0 | 2 109 | 8 | 0 | 0 |
| Total | 10 091 | 10 241 | 8 683 | 9 559 | 3 031 | 10 306 |
| (in NOK 000) | Note | 2025 | 2024 |
| Wafer and assembly production cost, outsourced | 2 693 | 2 097 | |
| Customer customisations, employee expense | 5.3 | 295 | 19 |
| Final testing, employee expense | 5.3 | 403 | 67 |
| Depreciation of final testing equipment | 8 | 113 | 25 |
| Total Cost of goods | |||
| sold | 3 504 | 2 208 |
| (in NOK 000) | Note | 2025 | 2024 |
| Employee benefits expense1) | 5.3 | 92 702 | 70 401 |
| Depreciation and amortisation | 10 628 | 10 489 | |
| Other operating expenses | 32 787 | 28 720 | |
| Total operating expenses | 136 117 | 109 610 |
| (in NOK 000) | 2025 | 2024 |
| Included in Research and development expenses: | ||
| Wages and salaries | 12 537 | 10 388 |
| Consultants engaged on long-term contracts | 10 664 | 9 214 |
| Social security costs | 2 220 | 1 979 |
| Pension costs | 651 | 514 |
| Other benefits and social costs | 451 | 645 |
| Share based compensation costs | 5 083 | 2 154 |
| Grants | -527 | -323 |
| Included in Sales and marketing expenses: | ||
| Wages and salaries | 3 744 | 2 572 |
| Consultants engaged on long-term contracts | 8 492 | 7 834 |
| Social security costs | 663 | 490 |
| Pension costs | 194 | 127 |
| Other benefits and social costs | 135 | 160 |
| Share based compensation costs | 2 514 | 2 115 |
| Included in Operational / supply chain expenses: | ||
| Wages and salaries | 8 176 | 5 679 |
| Consultants engaged on long-term contracts | 5 125 | 8 054 |
| Social security costs | 1 395 | 1 082 |
| Pension costs | 409 | 281 |
| Other benefits and social costs | 283 | 353 |
| Share based compensation costs | 3 887 | 1 460 |
| Internal assembly and testing (COGS) | -698 | 0 |
| Included in Administrative expenses: | ||
| Wages and salaries | 15 316 | 12 571 |
| Consultants engaged on long-term contract | 1 075 | 287 |
| Social security costs | 2 712 | 2 394 |
| Pension costs | 795 | 622 |
| Other benefits and social costs | 551 | 781 |
| Share based compensation costs | 6 855 | -1 032 |
| Total employee benefits expense | 92 702 | 70 401 |
| Average number of man-years, employees | 27 | 27 |
| Average number of man-years, total | 46 | 45 |
| (in NOK 000) | 2025 | 2024 |
| Defined contribution plan | 1 928 | 1 467 |
| Employer’s national insurance contribution | 272 | 207 |
| Total pension cost | 2 200 | 1 674 |
| (in NOK 000) | 2025 | 2024 |
| Share based compensation costs | 15 223 | 10 008 |
| Employer’s national insurance contribution | 3 116 | -5 312 |
| Recognised as employee benefits expense | 18 339 | 4 697 |
| Remaining | |||||||
| Outstanding | Exercisable | Remaining | Total | estimated | |||
| Exercise price | no. of share | no. of share | contractual | expensed (in | expense (in | ||
| Year granted | Note | (NOK) | options | options | life (years) | NOK 000) | NOK 000) |
| 2019 | 1 | 3.78 | 157 215 | 157 215 | 1.75 | 574 | 0 |
| 2023 | 2 | 12.15 | 0 | 0 | 0.00 | 6 879 | 668 |
| 2023 | 2 | 12.82 | 0 | 0 | 0.00 | 2 087 | 3 |
| 2024 | 2 | 3.20 | 4 935 330 | 2 423 073 | 3.46 | 6 013 | 1 139 |
| 2024 | 4.33 | 533 334 | 212 497 | 3.72 | 992 | 330 | |
| 2025 | 5.11 | 250 000 | 62 500 | 4.01 | 369 | 203 | |
| 2025 | 3.95 | 9 618 334 | 1 593 324 | 4.45 | 9 363 | 11 765 | |
| 15 494 213 | 4 448 609 | 4.07 | 26 276 | 14 107 |
| 2025 | 2024 | |||
| Number of | WAEP | Number of | WAEP | |
| share options | share options | |||
| Outstanding at 1 January | 6 271 705 | 3.3 | 5 579 066 | 11.3 |
| Granted during the year | 10 115 000 | 4.0 | 6 129 490 | 3.3 |
| Terminated during the year | -556 664 | 3.5 | -113 750 | 11.1 |
| Cancelled during the year | 0 | -5 304 490 | 11.7 | |
| Exercised during the year | -335 828 | 3.3 | -1 250 | 3.2 |
| Expired during the year | 0 | -17 361 | 22.8 | |
| Outstanding at 31 December | 15 494 213 | 3.7 | 6 271 705 | 3.3 |
| In % of outstanding shares | 7.28 % | 4.84 % | ||
| Exercisable at 31 December | 4 448 609 | 3.6 | 1 130 444 | 3.3 |
| 2025 | 2024 | |
| Price at grant date* | NOK 4.13 | NOK 3.85 |
| Exercise price* | NOK 3.98 | NOK 3.30 |
| Maximum1) option life | 5 years | 5 years |
| Assumed option life | 2.63 years | 2.63 years |
| Risk-free interest rate* | 3,76 % | 3.62 % |
| Volatility* | 86 % | 85 % |
| Fair value per share option* | NOK 2.19 | NOK 1.442) |
| (in NOK 000) | 2025 | 2024 |
| Employee benefits expense (incl. consultants) | 31 605 | 24 895 |
| Other operating expenses | 19 670 | 9 646 |
| Government grants | -2 205 | -2 217 |
| Capitalized | 0 | 0 |
| Total Research and development expenses | 49 070 | 32 323 |
| (in NOK 000) | 2025 | 2024 |
| Employee benefits expense (incl. consultants) | 15 742 | 13 298 |
| Other operating expenses | 4 350 | 3 007 |
| Total Sales and marketing expenses | 20 092 | 16 305 |
| (in NOK 000) | 2025 | 2024 |
| Employee benefits expense (incl. consultants) | 19 276 | 16 909 |
| Other operating expenses | 9 197 | 6 633 |
| Total Operational / supply chain expenses | 28 472 | 23 542 |
| (in NOK 000) | 2025 | 2024 |
| Employee benefits expense | 27 304 | 15 622 |
| Other operating expenses | 551 | 11 328 |
| Total Administrative expenses | 27 855 | 26 950 |
| (in NOK 000) | 2025 | 2024 |
| Statutory audit | 1 182 | 985 |
| Other attestation services | 485 | 279 |
| Tax consultancy | 132 | 38 |
| Other services that are not part of the audit | 102 | 128 |
| Total Auditor's remuneration(excluding VAT) | 1 900 | 1 430 |
| (in NOK 000) | 2025 | 2024 |
| Finance income | 0 | 211 |
| Interest income | 10 510 | 7 431 |
| Finance income | 10 510 | 7 642 |
| (in NOK 000) | 2025 | 2024 |
| Net foreign exchange losses | 424 | 404 |
| Interest expense on debts and borrowings | 4 | 4 |
| Interest expense on lease liabilities | 961 | 252 |
| Finance expenses | 26 | 25 |
| Finance cost | 1 414 | 685 |
| (in NOK 000) | 2025 | 2024 |
| Consolidated statement of profit or loss | ||
| Current income tax expense | 207 | 139 |
| Deferred tax: | ||
| Relating to origination and reversal of temporary differences | 0 | 0 |
| Income tax expense reported in the statement of profit or loss | 207 | 139 |
| (in NOK 000) | 2025 | 2024 |
| Calculated income tax at statutory rate of 22% | -25 972 | -22 362 |
| Government grants exempt from tax | -504 | -428 |
| Tax effect of permanent differences 1) | 3 845 | 1 083 |
| Change in unrecognised deferred tax assets | 22 738 | 22 122 |
| Effect of different tax rates compared with Norwegian tax rate | -326 | -249 |
| Foreign currency effects | 410 | 112 |
| Adjustments previous year | 16 | -139 |
| Income tax expense | 207 | 139 |
| Effective tax rate | 0,2 % | 0,1 % |
| Balance at 31 December | ||||||
| 2025 | Net balance at | Recognised in | Recognised in | Deferred tax | Deferred tax | |
| (in NOK 000) | 1 January | profit or loss | OCI | Net | assets | liabilities |
| Property, plant and | ||||||
| equipment | -220 | 60 | 0 | -160 | 0 | -160 |
| Intangible assets | 4 896 | -135 | 0 | 4 761 | 4 761 | 0 |
| Inventories | 4 698 | 1 916 | 0 | 6 613 | 6 613 | 0 |
| Group loan | -2 156 | 0 | -25 | -2 181 | 0 | -2 181 |
| Provisions | 1 613 | -1 393 | 0 | 220 | 220 | 0 |
| Tax losses carried forward | 206 784 | 25 433 | 0 | 232 217 | 232 217 | 0 |
| Tax assets (liabilities) before | ||||||
| set-off | 215 614 | 25 881 | -25 | 241 471 | 243 811 | -2 341 |
| Set-off of tax | 0 | -2 341 | 2 341 | |||
| Unrecognised deferred tax | ||||||
| assets | -215 614 | -25 881 | 25 | -241 471 | -241 471 | |
| Net tax assets (liabilities) | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance at 31 December | ||||||
| 2024 | Net balance | Recognised in | Recognised in | Deferred tax | Deferred tax | |
| (in NOK 000) | at 1 January | profit or loss | OCI | Net | assets | liabilities |
| Property, plant and | ||||||
| equipment | -87 | -134 | 0 | -220 | 0 | -220 |
| Intangible assets | 5 031 | -135 | 0 | 4 896 | 4 896 | 0 |
| Inventories | 3 288 | 1 410 | 0 | 4 698 | 4 698 | 0 |
| Group loan | -1 833 | 0 | -323 | -2 156 | 0 | -2 156 |
| Provisions | 220 | 1 393 | 0 | 1 613 | 1 613 | 0 |
| Tax losses carried forward | 182 101 | 24 682 | 0 | 206 784 | 206 784 | 0 |
| Tax assets (liabilities) before | ||||||
| set-off | 188 720 | 27 217 | -323 | 215 614 | 217 990 | -2 376 |
| Set-off of tax | 0 | -2 376 | 2 376 | |||
| Unrecognised deferred tax | ||||||
| assets | -188 720 | -27 217 | 323 | -215 614 | -215 614 | |
| Net tax assets (liabilities) | 0 | 0 | 0 | 0 | 0 | 0 |
| (in NOK 000) | 2025 | 2024 |
| Norway (no expiry date) | 237 110 | 211 225 |
| France (no expiry date) | 4 360 | 4 388 |
| Total unrecognised deferred tax assets | 241 471 | 215 614 |
| 2025 | 2024 | |
| Weighted average number of ordinary shares for basic EPS | 175 337 522 | 104 962 138 |
| Effect of dilution: | ||
| Share options in-the-money (average) | 2 390 124 | 484 537 |
| Anti-dilutive for the periods presented | -2 390 124 | -484 537 |
| Weighted average number of shares adjusted for the effect of dilution | 175 337 522 | 104 962 138 |
| (in NOK) | 2025 | 2024 |
| Profit / loss (-) attributable to ordinary equity holders of the parent | -118 261 | -101 785 |
| Earnings per share for income attributable to equity holders of poLight: | ||
| Basic | -0.67 | -0.97 |
| Diluted | -0.67 | -0.97 |
| Leasehold | |||
| (in NOK 000) | improvements | Equipment | Total |
| Cost at 1 January 2024 | 1 248 | 22 123 | 23 371 |
| Additions | 27 | 2 375 | 2 402 |
| Disposals at cost | -68 | -91 | -159 |
| Foreign currency translation effect | 0 | 109 | 109 |
| Cost at 31 December 2024 | 1 207 | 24 516 | 25 723 |
| Accumulated depreciation and impairment losses at 1 January 2024 | -598 | -13 533 | -14 131 |
| Depreciation | -249 | -1 811 | -2 060 |
| Impairment losses | 0 | -26 | -26 |
| Accumulated depreciation and impairment losses disposals | 41 | 91 | 132 |
| Effect of changes in foreign exchange | 0 | -79 | -79 |
| Accumulated depreciation and impairment losses at 31 December 2024 | -805 | -15 359 | -16 164 |
| Net book value at 31 December 2024 | 402 | 9 157 | 9 559 |
| Leasehold | |||
| (in NOK 000) | improvements | Equipment | Total |
| Cost at 1 January 2025 | 1 207 | 24 516 | 25 723 |
| Additions | 0 | 1 681 | 1 681 |
| Disposals at cost | 0 | -90 | -90 |
| Foreign currency translation effect | 0 | 10 | 10 |
| Cost at 31 December 2025 | 1 207 | 26 117 | 27 324 |
| Accumulated depreciation and impairment losses at 1 January 2025 | -805 | -15 359 | -16 164 |
| Depreciation | -243 | -2 274 | -2 517 |
| Accumulated depreciation and impairment losses disposals | 0 | 49 | 49 |
| Effect of changes in foreign exchange | 0 | -10 | -10 |
| Accumulated depreciation and impairment losses at 31 December 2025 | -1 048 | -17 593 | -18 641 |
| Net book value at 31 December | |||
| 2025 | 159 | 8 524 | 8 683 |
| Estimated useful lives | |||
| (years) | 1) | 3-7 |
| Development costs | Software | ||
| (in NOK 000) | and TLens patents | license | Total |
| Cost at 1 January 2024 | 78 184 | 181 | 78 365 |
| Cost at 31 December 2024 | 78 184 | 181 | 78 365 |
| Accumulated amortisation and impairment losses at 1 January 2024 | -60 604 | -181 | -60 785 |
| Amortisation | -7 275 | 0 | -7 275 |
| Accumulated amortisation and impairment losses at 31 December 2024 | -67 879 | -181 | -68 060 |
| Net book value at 31 December 2024 | 10 306 | 0 | 10 306 |
| Development costs | Software | ||
| (in NOK 000) | and TLens patents | license | Total |
| Cost at 1 January 2025 | 78 184 | 181 | 78 365 |
| Disposals | 0 | -110 | -110 |
| Cost at 31 December 2025 | 78 184 | 71 | 78 255 |
| Accumulated amortisation and impairment losses at 1 January 2025 | -67 879 | -181 | -68 059 |
| Amortisation | -7 275 | 0 | -7 275 |
| Disposals | 0 | 110 | 110 |
| Accumulated amortisation and impairment losses at 31 December | |||
| 2025 | -75 153 | -71 | -75 224 |
| Net book value at 31 December 2025 | 3 031 | 0 | 3 031 |
| Carrying amount | |||
| before | Carrying amount | Accumulated net | |
| (in NOK 000) | impairment | after impairment | impairment loss |
| CGU: TLens® technology platform | |||
| At 31 December 2024 | 28 586 | 10 306 | 18 280 |
| At 31 December 2025 | 21 311 | 3 031 | 18 280 |
| (in NOK 000) | 2025 | 2024 |
| At 1 January | 10 241 | 2 915 |
| Additions | 907 | 10 324 |
| Termination of contract | 0 | -1 846 |
| Depreciation expense | -1 057 | -1 153 |
| At 31 December | 10 091 | 10 241 |
| (in NOK 000) | 2025 | 2024 |
| At 1 January | 10 278 | 3 133 |
| Additions | 907 | 10 324 |
| Termination of contract | 0 | -2 052 |
| Interest expense | 961 | 252 |
| Payments | -1 675 | -1 380 |
| At 31 December | 10 470 | 10 278 |
| Current, < 1 year | 783 | 663 |
| Non-current | 9 687 | 9 615 |
| (in NOK 000) | 2025 | 2024 |
| Depreciation expense of right-of-use assets | 1 057 | 1 153 |
| Interest expense on lease liabilities | 961 | 252 |
| Expense relating to short-term leases (included in research and development expenses) | 561 | 535 |
| Expense relating to short-term leases (included in sales and marketing expenses) | 0 | 868 |
| Expense relating to leases of low-value assets (included in administrative expenses) | 54 | 47 |
| Total amount recognised in profit or loss | 2 634 | 2 854 |
| (in NOK 000) | 2025 | 2024 |
| Components; mainly wafers (at cost) | 78 267 | 77 472 |
| Finished goods; lenses and driver ASICs (at cost) | 5 309 | 6 312 |
| Obsolescence provision | -30 061 | -21 353 |
| Total inventories at the lower of cost and net realisable value | 53 515 | 62 431 |
| (in NOK 000) | 2025 | 2024 |
| Financial assets at amortised cost: | ||
| Trade receivables | 6 697 | 217 |
| Grants recognised, not received | 2 292 | 1 946 |
| Other receivables | 1 002 | 1 629 |
| Total financial assets | 9 991 | 3 792 |
| Total current | 9 991 | 3 792 |
| Total non-current | 0 | 0 |
| (in NOK 000) | Interest rate | Maturity | 2025 | 2024 |
| Current interest-bearing loans and borrowings: | ||||
| Lease liabilities (Note 11 Lease agreements) | 9,9 % | < 1 year | 783 | 663 |
| Secured loan, DnB | 0.99% | < 1 year | 57 | 57 |
| Total | 840 | 720 |
| (in NOK 000) | Interest rate | Maturity | 2025 | 2024 |
| Non-current interest-bearing loans and borrowings: | ||||
| Lease liabilities (Note 11 Lease agreements) | 9,9 % | 2034 | 9 687 | 9 615 |
| Secured loan, DnB | 0.99/6.35% | 2032 | 311 | 369 |
| Total | 9 998 | 9 984 |
| (in NOK 000) | 2025 | 2024 |
| Financial liabilities at amortised cost, other than interest-bearing loans and | ||
| borrowings: | ||
| Trade payables | 8 345 | 6 571 |
| Other payables | 9 739 | 7 017 |
| Accrued employer’s NICs on share option plan (Note 5.3) | 3 642 | 527 |
| Provisions (Note 17) | 1 000 | 7 331 |
| Total | 22 725 | 21 447 |
| Total current | 22 725 | 21 447 |
| Total non-current | 0 | 0 |
| Past due | |||||||
| Not past | |||||||
| (in NOK 000) | Total | due | < 30 days | 30–60 days | 61–90 days | 91–120 days | > 120 days |
| 2025 | 9 991 | 7 203 | 2 719 | 16 | 53 | 0 | 0 |
| 2024 | 3 792 | 3 764 | 2 | 26 | 0 | 0 | 0 |
| 3 to 12 | |||||
| (in NOK 000) | < 3 months | months | 1 to 5 years | > 5 years | Total |
| As at 31. December 2025 | |||||
| Interest-bearing loans | 15 | 46 | 342 | 6 | 410 |
| Lease liabilities | 434 | 1 302 | 6 924 | 6 756 | 15 416 |
| Trade and other payables | 18 651 | 3 074 | 0 | 0 | 21 725 |
| 19 101 | 4 422 | 7 266 | 6 762 | 37 550 |
| 3 to 12 | |||||
| (in NOK 000) | < 3 months | months | 1 to 5 years | > 5 years | Total |
| As at 31. December 2024 | |||||
| Interest-bearing loans | 15 | 46 | 342 | 76 | 480 |
| Lease liabilities | 398 | 1 192 | 6 338 | 7 741 | 15 668 |
| Trade andother payables | 11 764 | 2 352 | 0 | 0 | 14 116 |
| 12 177 | 3 590 | 6 680 | 7 817 | 30 264 |
| (in NOK 000) | 2025 | 2024 |
| Interest-bearing loans | 368 | 426 |
| Trade and other payables | 22 725 | 21 447 |
| Less: cash and short-term deposits | -283 981 | -166 752 |
| Net debt | -260 888 | -144 879 |
| (in NOK 000) | 2025 | 2024 |
| Receivable at 1 January | 1 946 | 2 117 |
| Received during the year | -1 859 | -2 388 |
| Grants recognised as reduction of research and development expenses in the consolidated statement | ||
| of income | 2 205 | 2 217 |
| Receivable at 31 December | 2 292 | 1 946 |
| (in NOK 000) | 2025 | 2024 |
| Current | 2 292 | 1 946 |
| Non-current | 0 | 0 |
| Total | 2 292 | 1 946 |
| (in NOK 000) | 2025 | 2024 |
| Cash at banks | 282 116 | 165 572 |
| Restricted cash, taxes withheld | 1 865 | 1 180 |
| Cash and short-term deposits | 283 981 | 166 752 |
| 2025 | 2024 | |
| Ordinary shares | 212 768 478 | 129 621 605 |
| Number of | Issued capital | |
| Shares issued and fully paid | shares | (in NOK 000) |
| At 1 January 2024 of NOK 0.20 each | 66 211 548 | 2 649 |
| Rights Issue on 21 May 2024 each with a par value of NOK 0.04 | 60 481 758 | 2 419 |
| Underwriting commission related to the rights Issue on 21 May 2024 each with a par | ||
| value of NOK 0.04 | 2 928 299 | 117 |
| At 31 December 2024 | 129 621 605 | 5 185 |
| Private placement (Q Technology Group) on 4 June 2025 each with a par value of NOK | ||
| 0.04 | 63 743 112 | 2 550 |
| Subsequent offering on 7 July 2025 each with a par value of NOK 0.04 | 19 122 933 | 765 |
| Exercise of share options on 20 August 2025 each with a par value of NOK 0.04 | 81 559 | 3 |
| Exercise of share options on 21 November 2025 each with a par value of NOK 0.04 | 199 269 | 8 |
| At 31 December 2025 | 212 768 478 | 8 511 |
| (in NOK 000) | Share premium |
| At 1 January 2024 | 194 503 |
| Rights Issue on 21 May 2024 each with a par value of NOK 0.04 | 143 846 |
| Decrease due to transaction costs for issued share capital | -22 419 |
| Allocated to retain earnings | -93 556 |
| At 31 December 2024 | 222 373 |
| Private placement (Q Technology Group) on 4 June 2025 each with a par value of NOK 0.04 | 168 919 |
| Subsequent offering on 7 July 2025 each with a par value of NOK 0.04 | 50 676 |
| Exercise of share options on 20 August 2025 each with a par value of NOK 0.04 | 258 |
| Exercise of share options on 21 November 2025 each with a par value of NOK 0.04 | 672 |
| Decrease due to transaction costs for issued share capital | -13 376 |
| Allocated to retain earnings | -103 615 |
| At 31 December 2025 | 325 907 |
| Warranty | |||
| (in NOK 000) | provision | Claims | Total |
| At 1 January 2024 | 1 000 | 0 | 1 000 |
| New or increased provisions | 0 | 6331 | 6331 |
| At 31 December 2024 | 1 000 | 6 331 | 7 331 |
| New or increased provisions | 0 | 0 | 0 |
| Utilised | 0 | -6 331 | -6 331 |
| At 31 December 2025 | 1 000 | 0 | 1 000 |
| Warranty | |||
| (in NOK 000) | provision | Claims | Total |
| Current, < 1 year | 1 000 | 0 | 1 000 |
| Non-current | 0 | 0 | 0 |
| At 31 December 2025 | 1 000 | 0 | 1 000 |
| Country of | ||||
| Name | Principal activities | incorporation | 2025 | 2024 |
| R&D, Sales and | ||||
| poLight ASA | management | Norway | 100 % | 100 % |
| poLight France SAS | R&D | France | 100 % | 100 % |
| poLight Finland Oy | R&D | Finland | 100 % | 100 % |
| poLight Hong Kong Limited | Holding company | HK, China | 100 % | 100 % |
| poLight (Shenzhen) Technical | ||||
| Service Company Limited | Sales | China | 100 % | 100 % |
| (in NOK 000) | 2025 | 2024 |
| Purchases from subsidiaries | 17 115 | 16 617 |
| Outstanding balances | 2025 | 2024 | ||
| EUR 000 | NOK 000 | EUR 000 | NOK 000 | |
| Subordinated loan agreement | 2 600 | 30 200 | 2 650 | 31 257 |
| Trade and other payables | 2 063 | 3 238 | ||
| Value1) | |||||||
| Pension | Other | share | Total | Total | |||
| (in NOK 000) | Salaries | Bonus | costs | benefits | options | 2025 | 2024 |
| Øyvind Isaksen - CEO | 3 818 | 2 613 | 212 | 438 | 3 742 | 10 823 | 7 382 |
| Pierre Craen - CTO 2) | 2 709 | 528 | 0 | 0 | 934 | 4 172 | 3 078 |
| Marianne Sandal - COO | 1 966 | 345 | 236 | 104 | 962 | 3 613 | 2 643 |
| Joakim Bredahl- CFO 3) | 1 590 | 309 | 198 | 31 | 828 | 2 956 | 800 |
| Total management team | 10 083 | 3 795 | 645 | 573 | 6 467 | 21 563 | 13 903 |
| Opening | Cancelled | Exercised | Granted | Ending | Exercisable | |
| balance | options | options | options | balance | options | |
| Øyvind Isaksen - CEO | 2 083 745 | 0 | 0 | 2 250 000 | 4 333 745 | 1 495 480 |
| Pierre Craen - CTO | 410 615 | 0 | 0 | 645 000 | 1 055 615 | 312 807 |
| Marianne Sandal - COO | 458 615 | 0 | 0 | 645 000 | 1 103 615 | 336 807 |
| Joakim Bredahl-CFO | 250 000 | 0 | 0 | 645 000 | 895 000 | 232 500 |
| Total management team | 3 202 975 | 0 | 0 | 4 185 000 | 7 387 975 | 2 377 594 |
| (in NOK 000) | 2025 | 2024 |
| Grethe Viksaas - chair of the board | 563 | 538 |
| Svenn Tore Larsen | 283 | 270 |
| Thomas Görling1) | 138 | 270 |
| Jean-Christophe Eloy2) | 283 | 231 |
| Marianne Bøe2) | 283 | 231 |
| Cathrine Wiig Ore 3) | 145 | 0 |
| Chris Liu4) | 145 | 0 |
| Louis So4) | 145 | 0 |
| Ann-Tove Kongsnes5) | 0 | 39 |
| Total Board of Directors | 1 983 | 1 578 |
| (in NOK 000) | 2025 | 2024 |
| Jan-Erik Hæreid-chair1) | 40 | 39 |
| Thomas S. Wrede-Holm - former chair 2) | 0 | 6 |
| Anne E. H. Worsøe | 30 | 30 |
| Egil Garberg 3) | 30 | 26 |
| Total | 100 | 100 |
| (in NOK 000) | 2025 | 2024 |
| Marianne Bøe - chair 1) | 40 | 34 |
| Ann-Tove Kongsnes - former chair 2) | 0 | 6 |
| Grethe Viksaas | 30 | 30 |
| Louis So3) | 15 | 0 |
| Total | 85 | 70 |
| (in NOK 000) | 2025 | 2024 |
| Grethe Viksaas - chair | 40 | 35 |
| Svenn Tore Larsen1) | 15 | 0 |
| Chris Liu2) | 15 | 0 |
| Thomas Görling3) | 15 | 30 |
| Total | 85 | 65 |
| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| Sale of goods | 2 | 19 370 | 7 586 |
| Rendering of services | 2 | 1 114 | 2 038 |
| Revenue | 20 484 | 9 624 | |
| Change in obsolescence provision | 13 | 8 013 | 6 409 |
| Cost of goods sold | 3 504 | 2 208 | |
| Gross profit | 8 967 | 1 007 | |
| Research and development expenses | -50 272 | -34 017 | |
| Sales and marketing expenses | -21 622 | -17 835 | |
| Operational / supply chain expenses | -28 472 | -23 542 | |
| Administrative expenses | -29 531 | -28 330 | |
| Depreciation, amortisation and net impairment losses | 10,11 | -9 551 | -9 304 |
| Operating profit / loss (-) | -130 481 | -112 020 | |
| Finance income | 8 | 12 144 | 10 347 |
| Finance costs | 8 | -501 | -1 892 |
| Net financial items | 11 643 | 8 456 | |
| Profit / loss (-) before tax | -118 838 | -103 564 | |
| Income tax expense | 9 | 0 | 0 |
| Profit / loss (-) for the year | -118 838 | -103 564 | |
| Allocated to/from: | |||
| Share premium | 17 | -103 615 | -93 556 |
| Retained earnings | 17 | -15 223 | -10 008 |
| Profit / loss (-) for the year | -118 838 | -103 564 |
| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| ASSETS | |||
| Property, plant and equipment | 10 | 8 648 | 9 502 |
| Intangible assets | 11 | 3 031 | 10 306 |
| Investments in subsidiaries | 12 | 320 | 320 |
| Subordinated loan to subsidiaries | 14,21 | 2 240 | 2 800 |
| Total non-current assets | 14 239 | 22 927 | |
| Inventories | 13 | 53 515 | 62 431 |
| Trade receivables | 14 | 6 697 | 217 |
| Other receivables | 14 | 6 788 | 4 085 |
| Cash and cash equivalents | 15 | 276 465 | 160 688 |
| Total current assets | 343 465 | 227 420 | |
| Total assets | 357 704 | 250 347 | |
| EQUITY AND LIABILITIES | |||
| Share capital | 16,17 | 8 511 | 5 185 |
| Share premium | 17 | 325 907 | 222 373 |
| Total equity | 334 418 | 227 558 | |
| Interest-bearing loans and borrowings | 18 | 368 | 426 |
| Total non-current liabilities | 368 | 426 | |
| Trade payables | 14 | 10 056 | 9 115 |
| Public duties payable | 6 681 | 2 606 | |
| Other payables | 14 | 6 181 | 10 643 |
| Total current liabilities | 22 918 | 22 363 | |
| Total liabilities | 23 286 | 22 789 | |
| Total equity and liabilities | 357 704 | 250 347 |
| Grethe Viksaas (sign) Chairperson | Svenn-Tore Larsen (sign) Board member | Jean-Christophe Eloy (sign) Board member | Marianne Bøe (sign) Board member |
|---|---|---|---|
| Cathrine Wiig Ore (sign) | Chris Liu (sign) | Louis So (sign) | Dr Øyvind Isaksen (sign) |
| Board member | Board member | Board member | Chief Executive Officer |
| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| Operating activities | |||
| Profit before tax | -118 838 | -103 564 | |
| Gain on disposal of property, plant and | |||
| equipment | -8 | 0 | |
| Depreciation, amortisation and net impairment losses | 10,11 | 9 551 | 9 304 |
| Depreciation of final testing equipment recognised as Cost of goods sold | 10 | 222 | 25 |
| Changes in inventories, trade receivables and trade payable | 3 377 | 12 646 | |
| Changes in other accruals | 10 947 | 8 791 | |
| Net cash flows from / (used in) operating activities | -94 749 | -72 800 | |
| Investing activities | |||
| Proceeds from sale of property, plant and equipment | 45 | 0 | |
| Purchase of property, plant and equipment | 10 | -1 681 | -2 402 |
| Proceeds from group borrowings | 14,21 | 1 169 | 0 |
| Dividend from subsidiaries | 8 | 576 | 933 |
| Net cash flows from / (used in) investing activities | 109 | -1 469 | |
| Financing activities | |||
| Proceeds from Issue of ordinary shares | 17 | 222 910 | 146 382 |
| Proceeds from exercise of share options | 17 | 941 | 0 |
| Transaction costs on issue of shares | 17 | -13 376 | -22 419 |
| Proceeds from borrowings | 18 | 0 | 474 |
| Repayment of borrowings | 18 | -58 | -48 |
| Net cash flows from / (used in) financing activities | 210 417 | 124 389 | |
| Net increase in cash and cash equivalents | 115 777 | 50 120 | |
| Cash and cash equivalents at 1 January | 15 | 160 688 | 110 568 |
| Cash and cash equivalents at 31 December | 15 | 276 465 | 160 688 |
| (in NOK 000) | 2025 | 2024 |
|---|---|---|
| By business area | ||
| TLens® | 20 484 | 9 624 |
| Total | 20 484 | 9 624 |
| Geographical distribution | ||
| America | 8 875 | 4 982 |
| Asia | 10 787 | 4 410 |
| Europe | 822 | 232 |
| Total | 20 484 | 9 624 |
| (in NOK 000) | Note | 2025 | 2024 |
|---|---|---|---|
| Employee benefits expense1) | 5,6 | 80 689 | 58 992 |
| Depreciation, amortisation and net impairment losses | 10,11 | 9 551 | 9 304 |
| Other operating expenses | 7,19 | 49 208 | 44 732 |
| Total operating expenses | 139 448 | 113 027 |
| 4 Government grants | ||
| (in NOK 000) | 2025 | 2024 |
| At 1 January | 1 946 | 2 117 |
| Received during the year | -1 859 | -2 388 |
| Grants earned | 2 205 | 2 217 |
| At 31 December | 2 292 | 1 946 |
| (in NOK 000) | 2025 | 2024 |
|---|---|---|
| Wages and salaries | 30 198 | 22 130 |
| Consultants engaged on long-term contract | 25 355 | 25 456 |
| Social security costs | 4 602 | 3 618 |
| Pension costs (note 6) | 2 063 | 1 544 |
| Other benefits and social costs | 1 358 | 1 870 |
| Share based compensation costs | 18 339 | 4 697 |
| Government grants | -527 | -323 |
| Internal assembly and testing (COGS) | -698 | 0 |
| Total employee benefits expense | 80 689 | 58 992 |
| Average number of man-years, employees | 18 | 18 |
| Average number of man-years, total | 37 | 36 |
| (in NOK 000) | 2025 | 2024 |
|---|---|---|
| Defined contribution plan | 1 928 | 1 467 |
| Social security | 272 | 207 |
| Total pension cost | 2 200 | 1 674 |
| (in NOK 000) | 2025 | 2024 |
|---|---|---|
| Statutory audit | 1 150 | 956 |
| Other attestation services | 485 | 279 |
| Tax consultancy | 132 | 38 |
| Other services that are not part of the audit1) | 102 | 128 |
| Total (excluding VAT) | 1 868 | 1 401 |
| (in NOK 000) | 2025 | 2024 |
|---|---|---|
| Interest income from group companies *) | 0 | 0 |
| Other interest income | 10 510 | 7 431 |
| Currency gain on loan to group companies | 480 | 1 469 |
| Dividend subsidiaries | 576 | 933 |
| Other financial income (currency gain) | 946 | 514 |
| Total finance income | 12 513 | 10 347 |
| (in NOK 000) | 2025 | 2024 |
|---|---|---|
| Other interest expenses | 4 | 4 |
| Impairment of group loan | -497 | 969 |
| Other financial expenses (currency loss) | 995 | 918 |
| Total finance expenses | 501 | 1 892 |
| Income tax expense | ||
| (in NOK 000) | 2025 | 2024 |
| Current income tax | ||
| expense | 0 | 0 |
| Changes in deferred tax | 0 | 0 |
| Total income tax expense | 0 | 0 |
| (in NOK 000) | 2025 | 2024 |
|---|---|---|
| Profit before income | ||
| tax | -118 838 | -103 564 |
| Permanent differences | 17 479 | 4 921 |
| Transaction costs on issue of shares | -13 376 | -22 419 |
| Government grants exempt from tax | -2 292 | -1 946 |
| Temporary differences | 1 429 | 11 019 |
| Adjustments previous year | 6 005 | -633 |
| Tax base | -109 593 | -112 622 |
| Temporary differences: | ||
|---|---|---|
| (in NOK 000) | 2025 | 2024 |
| Inventories | 30 061 | 21 353 |
| Fixed assets | -728 | -1 002 |
| Intangible assets | 21 640 | 22 253 |
| Group loan | 18 048 | 18 657 |
| Provisions | 1 000 | 7 331 |
| Tax losses carry forward | 1 035 503 | 919 979 |
| Net deferred tax assets/(liabilities) | 1 105 525 | 988 572 |
| 22 % deferred tax asset/(liability) | 243 215 | 217 486 |
| Unrecognised deferred tax assets | -243 215 | -217 486 |
| Recognised net deferred tax assets | 0 | 0 |
| (in NOK 000) | 2025 |
|---|---|
| Calculated income tax at statutory rate of 22% | -26 144 |
| Tax effect of permanent differences | 903 |
| Government grants exempt from tax | -504 |
| Change in unrecognised deferred tax assets | 25 730 |
| Adjustments previous year | 16 |
| Income tax expense | 0 |
| Effective tax rate | 0 % |
| (in NOK 000) | Building | Equipment | Total |
| Cost at 1 January 2025 | 1 207 | 22 083 | 23 290 |
| Additions | 0 | 1 681 | 1 681 |
| Disposals at cost | 0 | -90 | -90 |
| Cost at 31 December 2025 | 1 207 | 23 674 | 24 881 |
| Accumulated depreciation | -1 048 | -15 185 | -16 233 |
| Accumulated impairment losses | 0 | 0 | 0 |
| Accumulated depreciation and impairment losses at 31 December 2025 | -1 048 | -15 185 | -16 233 |
| Net book value at 31 December 2025 | 159 | 8 490 | 8 648 |
| Impairment losses for the year | 0 | 0 | 0 |
| Depreciation of equipment recognised as Cost of goods sold for the | |||
| year | 0 | 222 | 222 |
| Depreciation for the year | 243 | 2 033 | 2 276 |
| Estimated useful lives (years) | Note 1) | 3-7 | |
| Amortisation plan | Linear | Linear |
| Development | |||
| costs and | Software | ||
| (in NOK 000) | TLens patents | license | Total |
| Cost at 1 January 2025 | 78 184 | 110 | 78 294 |
| Disposals | 0 | -110 | -110 |
| Cost at 31 December 2025 | 78 184 | 0 | 78 184 |
| Accumulated amortisation | -56 873 | 0 | -56 873 |
| Accumulated impairment losses | -18 280 | 0 | -18 280 |
| Accumulated amortisation and impairment losses at 31 | |||
| December 2025 | -75 153 | 0 | -75 153 |
| Net book value at 31 December 2025 | 3 031 | 0 | 3 031 |
| Amortisation for the year | 7 275 | 0 | 7 275 |
| Estimated useful lives (years) | 3-7 | 3-7 | |
| Amortisation plan | Linear | Linear |
| Date of | Share | Voting | ||
| Company | foundation | Location | ownership | rights |
| poLight France SAS | 19.08.2010 | Lyon, France | 100 % | 100 % |
| poLight Finland Oy | 15.09.2016 | Tampere, Finland | 100 % | 100 % |
| poLight Hong Kong Limited | 08.12.2016 | HK, China | 100 % | 100 % |
| poLight (Shenzhen) Technical Service Company | ||||
| Limited | 24.04.2017 | Shenzhen, China | 100 % | 100 % |
| Number of | Net profit | ||||
| Company | Share capital | shares | Book value | Equity | 2025 |
| NOK 000 | NOK 000 | NOK 000 | NOK 000 | ||
| poLight France SAS | 80 | 10 000 | 0 | -21 040 | 299 |
| poLight Finland Oy | 23 | 100 | 23 | 1 225 | 690 |
| poLight Hong Kong Limited | 202 | 200 000 | 202 | 202 | 0 |
| poLight (Shenzhen) Technical Service Company | |||||
| Limited | 246 | 200 000 | 94 | 3 893 | 1 423 |
| (in NOK 000) | 2025 | 2024 |
| Work in progress (at cost) | 78 267 | 77 472 |
| Finished goods (at cost) | 5 309 | 6 312 |
| Obsolescence provision (expensed as Cost of goods sold) | -30 061 | -21 353 |
| Total inventories at the lower of cost and net realisable value | 53 515 | 62 431 |
| (in NOK 000) | 2025 | 2024 |
| Trade receivables | 0 | 0 |
| Other receivables | 0 | 0 |
| Total | 0 | 0 |
| (in NOK 000) | 2025 | 2024 |
| Non-current receivables | 30 200 | 31 257 |
| Impairment | -27 960 | -28 457 |
| Total | 2 240 | 2 800 |
| (in NOK 000) | 2025 | 2024 |
| Trade payables | 2 063 | 3 238 |
| Other payables | 0 | 0 |
| Total | 2 063 | 3 238 |
| (in NOK 000) | 2025 | 2024 |
| Cash at banks and on hand | 274 600 | 159 508 |
| Restricted cash, taxes withheld | 1 865 | 1 180 |
| Cash and short-term deposits | 276 465 | 160 688 |
| Number of | |||
| shares | Par value | Book value | |
| NOK | NOK 000 | ||
| Ordinary shares | 212 768 478 | 0.04 | 8 511 |
| Ordinary | Share- | ||
| Shareholders of poLight ASA at December 31, 2025 | shares | holding | Voting rights |
| % | % | ||
| Hongkong And Shanghai Banking Corp (nominee)(1) | 63 743 112 | 30.0 % | 30.0 % |
| Nordnet Bank AB (nominee) | 13569055 | 6.4 % | 6.4 % |
| LHH AS | 12 600 000 | 5.9 % | 5.9 % |
| Nordnet Livsforsikring AS | 8 640 571 | 4.1 % | 4.1 % |
| J.P. Morgan Se (nominee) | 2 991 824 | 1.4 % | 1.4 % |
| J.P. Morgan Se (nominee) | 2 811 557 | 1.3 % | 1.3 % |
| Indus Production Services AS | 2 000 000 | 0.9 % | 0.9 % |
| Bank Pictet & Cie (Europe) AG (nominee) | 2 000 000 | 0.9 % | 0.9 % |
| Trond Andersen | 1 300 000 | 0.6 % | 0.6 % |
| Aquery Holding AS | 1 292 697 | 0.6 % | 0.6 % |
| Richard Hanssen | 1 238 000 | 0.6 % | 0.6 % |
| Fjellstuens Eftf. AS | 1 084 227 | 0.5 % | 0.5 % |
| Erik Schellhorn | 1 064 237 | 0.5 % | 0.5 % |
| Cb Helse AS | 900 000 | 0.4 % | 0.4 % |
| Caceis Bank (nominee) | 800 000 | 0.4 % | 0.4 % |
| Stefan Sveen | 750 000 | 0.4 % | 0.4 % |
| Borgund Invest AS | 725 000 | 0.3 % | 0.3 % |
| Danske Bank A/S (nominee) | 713 887 | 0.3 % | 0.3 % |
| Arild Hansen Rødum | 705 951 | 0.3 % | 0.3 % |
| Åge Sverre Heggheim | 705 000 | 0.3 % | 0.3 % |
| Total number of shares owned by top 20 shareholders | 119 635 118 | 56.2 % | 56.2 % |
| Number of shares owned by other shareholders | 93 133360 | 43.8% | 43.8% |
| Total number of shares | 212 768 478 | 100.0 % | 100.0 % |
| Share | Share | Retained | ||
| (in NOK 000) | capital | premium | earnings | Total |
| Equity at 31 December 2024 | 5 185 | 222 373 | 0 | 227 558 |
| Loss for the period | -118 838 | -118 838 | ||
| Issue of ordinary shares | 3 315 | 219 595 | 0 | 222 910 |
| Share options exercised | 11 | 930 | 0 | 941 |
| Transaction costs | -13 376 | 0 | -13 376 | |
| Equity-settled share-based payment | 15 223 | 15 223 | ||
| Allocation to retained earnings | -103 615 | 103 615 | 0 | |
| Equity at 31 December 2025 | 8 511 | 325 907 | 0 | 334 418 |
| (in NOK 000) | Interest rate | 2025 | 2024 |
| Secured loan, DnB | 0.99/6.35% | 368 | 426 |
| Total | 368 | 426 |
| (in NOK 000) | 2025 | 2024 |
| Accounts receivable | 6 697 | 217 |
| Company car | 435 | 435 |
| Total | 7 132 | 652 |
| (in NOK 000) | 2025 | 2024 |
| Within one year | 1 769 | 1 622 |
| After one year but not more than five years | 7 024 | 6 501 |
| More than five years | 6 756 | 7 743 |
| Total | 15 549 | 15 867 |
| Warranty | |||
| (in NOK 000) | provision | Claims | Total |
| At 1 January 2025 | 1 000 | 6 331 | 7 331 |
| New or increased provisions | 0 | 0 | 0 |
| Utilised | 0 | -6 331 | -6 331 |
| Unused reversed as Cost of goods sold | 0 | 0 | 0 |
| At 31 December 2025 | 1 000 | 0 | 1 000 |
| Warranty | |||
| (in NOK 000) | provision | Claims | Total |
| Current, < 1 year | 1 000 | 0 | 1 000 |
| Non-current | 0 | 0 | 0 |
| At 31 December 2025 | 1 000 | 0 | 1 000 |